Softbank Vision FUND (aiv M1) L.P., 10% Owner at Vir Biotechnology, Inc. (VIR), sold 500,420 shares at $6.14 ($3.1M) on 2025-10-09, disclosed to the SEC on 2025-10-14.
Scheduled sale ($3.1M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.14 | 249,060 | $1.5M | 49.8% |
| 2 | $6.14 | 249,060 | $1.5M | 49.8% |
| 3 | $6.08 | 2,300 | $14K | 0.5% |
| Total | $6.14 avg | 500,420 | $3.1M | 100% |
| Filing → |
| COMP | SELL | 2023-06-09 | $55.4M | — | Filing → |
| VIR | SELL | 2023-04-18 | $1.0M | — | Filing → |
| VIR | SELL | 2023-02-17 | $1.0M | — | Filing → |